CSL's slow cure
Article Abstract:
Brian Mcnamee, the managing director of CSL is tackling major challenges of reviving the companies earning and rebuilding investor support. CSL's share prices went up by 40% indicating recovery from the worst period. The recovery is mainly due to the interest shown by international buyers.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Cochlear's high note
Article Abstract:
Cochlear Ltd. posted rise in share price by 150% and $221 million revenues for 2006. The business growth is attributed to managerial strategies of chief executive Chris Roberts.
Publication Name: Business Review Weekly
Subject: Business, general
ISSN: 0727-758X
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Top end revival. Fixing for fight
- Abstracts: Trapped by good intentions. The next step. Spread funding risks
- Abstracts: Broadcast believer. Bio's star turn. Tax office gets tough
- Abstracts: A tired, uncertain rally. The test of the rally. Rally falters
- Abstracts: What price Betcorp? Doubt on Tattersall's profit growth. Pokies jackpot overseas